Samantha J. Pearce - 28 May 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Jun 2026, 16:06:22 UTC
Prior SEC filing
09 Mar 2026
Next SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/Paz Dizon, as attorney in fact For: Samantha J. Pearce

Key filing fact

Samantha J. Pearce filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 01 Jun 2026.

Key facts

  • This page summarizes Samantha J. Pearce's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 01 Jun 2026, 16:06.

Change

  • Previous filing in this sequence was filed on 09 Mar 2026.
  • Current net transaction value: -$1,625,977.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001805688 Primary reporting owner

Pearce Samantha

Relationship
EVP, Chief Commercial Officer
Address
5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
Signature
By: /s/Paz Dizon, as attorney in fact For: Samantha J. Pearce
Signature date
01 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+6,907
Change %
+14%
Price
$109.45*
Shares after
57,179
Date
28 May 2026
Ownership
Direct
JAZZ transaction

Ordinary Shares

Sale

Transaction value
$1,625,977
Shares
-6,907
Change %
-12%
Price
$235.41
Shares after
50,272
Date
28 May 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JAZZ transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-6,907
Change %
-100%
Price
$0.000000*
Shares after
0
Date
28 May 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
6,907
Exercise price
$109.45
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020, 1/4th vested on the first anniversary of the vesting commencement date and the remainder vested in 36 equal monthly installments thereafter. The option was fully vested as of March 2, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .